Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bio-Rad buys Ciphergen proteomics instrument unit

This article was originally published in The Gray Sheet

Executive Summary

Bio-Rad Laboratories' $20 mil. cash purchase of Ciphergen Biosystems' proteomics instrument business, announced Aug. 14, includes surface enhanced laser desorption/ionization (SELDI) technology for life sciences applications and ProteinChip arrays and related software. Under the terms of the transaction, which includes a $3 mil. Bio-Rad equity investment in Ciphergen, the latter firm will retain SELDI rights for diagnostic applications. The deal furthers Ciphergen's strategy to focus on cancer diagnostics and other tests...

You may also be interested in...

Ciphergen Edges Proteomic Tests Closer To Market With Quest Backing

Ciphergen Biosystems hopes to begin clinical trial enrollment in February to support FDA clearance of an ovarian cancer triage test

UK Biotech Financing Holds Up Despite Woodford and Brexit

Neil Woodford’s fall from grace and Brexit dragged on an otherwise buoyant sector

Dr Reddy’s Focuses On India And China

Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts